Inhibition of PAD4-enabled citrullination by the PAD4 inhibitor, BB-Cl-amidine, significantly reduces the burden of CRC metastasis to the liver, where higher levels of PAD4 were observed compared to healthy liver and primary tumor (147). The gene discussed is PADI4; the disease is colorectal carcinoma.